The Role of NMDARs Ligands on Antinociceptive Effects of Pregabalin in the Tail Flick Test

Simple item page
AuthorManzumeh-Shamsi Meymandien
AuthorFariborz Keyhanfaren
AuthorOmid Yazdanpanahen
AuthorGioia Heravien
Issued Date2015-10-01en
AbstractBackground: Pregabalin as a new anticonvulsant has been used in different pain treatments. Objectives: The aim of this study was to investigate the role of N-methyl-D-aspartate (NMDA) ligands in antinociceptive effect of pregabalin in mice using tail flick. Materials and Methods: NMDA (15 and 30 mg/kg) as an agonist or MK801 (0.02 and 0.05 mg/kg) as an antagonist were injected intraperitoneally either alone or 15 minutes before antinociceptive dose of pregabalin (100 mg/kg). Then the latency times and %MPE were measured in the tail flick assay during 75 minutes. Results: NMDA and MK801 had no effects alone. NMDA pretreatment significantly decreased the latency times of pregabalin till 75th minutes. In NMDA pretreated groups, %MPE30 unlike %MPE75 decreased significantly compared to those of pregabalin. MK801 delayed the latency times in pretreated groups, but %MPE30 and %MPE75 did not change significantly compared to pregabalin alone. Conclusions: Our findings support the role of NMDARs in pregabalin antinociception, because the NMDAR agonist, unlike the antagonist, decreased the antinociceptive effect of pregabalin, even if tail flick is not an adequate pain assessment method in this regard.en
DOIhttps://doi.org/10.5812/aapm.28968en
KeywordLeucylarginineen
KeywordPregabalinen
KeywordMK801en
KeywordNMDAen
KeywordTail Flicken
KeywordN-Methyl-D-Aspartate (NMDA) Receptoren
PublisherBrieflandsen
TitleThe Role of NMDARs Ligands on Antinociceptive Effects of Pregabalin in the Tail Flick Testen
TypeResearch Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
17504-pdf.pdf
Size:
286.43 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF
Download

Collections

Anesthesiology and Pain Medicine